stockrowCytek Biosciences, Inc. (CTKB) vs InMode Ltd. (INMD)
- Cytek Biosciences, Inc. CTKB 5.84 +8.15%
- InMode Ltd. INMD 13.36 −0.30%
Cytek Biosciences, Inc. and InMode Ltd. are both Medical Devices companies. Cytek Biosciences, Inc. and InMode Ltd. are of similar size ($771.1M and $701.9M). Cytek Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; InMode Ltd. trades at 10.7×. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.50% against −6.71%. InMode Ltd. has the higher net margin (20.7% vs −39.1%) and the higher return on invested capital (33.8% vs −42.1%). Across the 19 metrics below, InMode Ltd. leads on 17 and Cytek Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | CTKB | INMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 54.75% | 76.52% | 57.76% |
| Operating margin | (21.13%) | 18.47% | (15.07%) |
| Net margin | (39.10%) | 20.69% | (14.45%) |
| Free cash flow margin | (6.43%) | 22.03% | (3.88%) |
| Return on equity | (23.20%) | 0.00% | (10.35%) |
| Return on assets | (17.26%) | 10.85% | (17.26%) |
| Return on invested capital | (42.08%) | 33.78% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack